EMD 5.56% 3.4¢ emyria limited

Ann: Global Pharmaceutical Expert joins Advisory Board, page-5

  1. 201 Posts.
    lightbulb Created with Sketch. 84
    EMD has a great chance because of the data they own. IHL is not over valued at all, they target conditions with no approved treatment so getting FDA approval would be easier. The board is second to none.
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
-0.002(5.56%)
Mkt cap ! $13.90M
Open High Low Value Volume
3.4¢ 3.4¢ 3.4¢ $18.70K 550.1K

Buyers (Bids)

No. Vol. Price($)
4 39378 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 42028 1
View Market Depth
Last trade - 10.59am 21/08/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.